Repurposing existing drugs for COVID-19: an endocrinology perspective

被引：0
作者：
Flavio A. Cadegiani
机构：
[1] Universidade Federal de São Paulo (EPM/UNIFESP),Adrenal and Hypertension Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina
来源：
BMC Endocrine Disorders | / 20卷
关键词：
COVID-19; SARS-CoV-2; ACE2; TMPRSS2; Pandemic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
    Tufan, Abdurrahman
    Avanoglu Guler, Aslihan
    Matucci-Cerinic, Marco
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 620 - 632
  • [22] Repurposing of drugs for COVID-19: a systematic review and meta-analysis
    Kotecha, Pinky
    Light, Alexander
    Checcucci, Enrico
    Amparore, Daniele
    Fiori, Cristian
    Porpiglia, Francesco
    Dasgupta, Prokar
    Elhage, Oussama
    PANMINERVA MEDICA, 2022, 64 (01) : 96 - 114
  • [23] A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
    Md. Shafiul Hossen
    Md Abdul Barek
    Nusrat Jahan
    Mohammad Safiqul Islam
    SN Comprehensive Clinical Medicine, 2020, 2 (10) : 1777 - 1789
  • [24] Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
    Andrade, Bruno Silva
    Rangel, Fernanda de Souza
    Santos, Naiane Oliveira
    Freitas, Andria dos Santos
    de Assis Soares, Wagner Rodrigues
    Siqueira, Sergio
    Barh, Debmalya
    Goes-Neto, Aristoteles
    Birbrair, Alexander
    de Carvalho Azevedo, Vasco Ariston
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [25] Editorial: Drug Repurposing for COVID-19 Therapy
    Maldonado, Rafael
    Drago, Filippo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] A review on drug repurposing applicable to COVID-19
    Dotolo, Serena
    Marabotti, Anna
    Facchiano, Angelo
    Tagliaferri, Roberto
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 726 - 741
  • [27] Immunosuppression for COVID-19: repurposing medicines in a pandemic
    Shivakumar, Senthuran
    Smibert, Olivia C.
    Trubiano, Jason A.
    Frauman, Albert G.
    Liew, David F. L.
    AUSTRALIAN PRESCRIBER, 2020, 43 (04) : 106 - 107
  • [28] A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
    Wattanakul, Thanaporn
    Chotsiri, Palang
    Scandale, Ivan
    Hoglund, Richard M.
    Tarning, Joel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 945 - 958
  • [29] Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs
    Majumder, Rajib
    Ghosh, Sanmitra
    Singh, Manoj K.
    Das, Arpita
    Roy Chowdhury, Swagata
    Saha, Abinit
    Saha, Rudra P.
    COVID, 2023, 3 (04): : 494 - 519
  • [30] COVID-19: A Risk Assessment Perspective
    Schroder, Imke
    ACS CHEMICAL HEALTH & SAFETY, 2020, 27 (03) : 160 - 169
12345